» Authors » Aparna Balasubramanian

Aparna Balasubramanian

Explore the profile of Aparna Balasubramanian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Regan E, Lowe M, Make B, Curtis J, Chen Q, Crooks J, et al.
Am J Respir Crit Care Med . 2023 Aug; 209(1):59-69. PMID: 37611073
The identification of early chronic obstructive pulmonary disease (COPD) is essential to appropriately counsel patients regarding smoking cessation, provide symptomatic treatment, and eventually develop disease-modifying treatments. Disease severity in COPD...
22.
Brems J, Balasubramanian A, Psoter K, Shah P, Bush E, Merlo C, et al.
Ann Am Thorac Soc . 2023 Jun; 20(10):1408-1415. PMID: 37315331
Interpretation of spirometry using race-specific reference equations may contribute to health disparities via underestimation of the degree of lung function impairment in Black patients. The use of race-specific equations may...
23.
Raju S, Woo H, Fawzy A, Putcha N, Balasubramanian A, Mathai S, et al.
Chronic Obstr Pulm Dis . 2023 Jun; 10(3):328-334. PMID: 37267605
Current measures of chronic obstructive pulmonary disease (COPD) severity, including lung function, do not fully explain symptom burden, and there is a need to identify predictors of exacerbation risk and...
24.
French M, Keatley E, Li J, Balasubramanian A, Hansel N, Wise R, et al.
Digit Health . 2023 May; 9:20552076231176160. PMID: 37214659
Objective: Clinical implementation of remote monitoring of human function requires an understanding of its feasibility. We evaluated adherence and the resources required to monitor physical, cognitive, and psychosocial function in...
25.
Regan E, Lowe M, Make B, Curtis J, Chen Q, Cho M, et al.
J Gen Intern Med . 2023 Apr; 38(13):2988-2997. PMID: 37072532
Background: COPD diagnosis is tightly linked to the fixed-ratio spirometry criteria of FEV/FVC < 0.7. African-Americans are less often diagnosed with COPD. Objective: Compare COPD diagnosis by fixed-ratio with findings...
26.
Balasubramanian A, Holbrook J, Canning B, Que L, Castro M, Make B, et al.
ERJ Open Res . 2023 Apr; 9(2). PMID: 37057088
Background: Cough is the most reported symptom in the United States, with chronic refractory cough representing significant morbidity to patients. Zinc acetate may have beneficial effects in the cough reflex...
27.
Raju S, Woo H, Koehler K, Fawzy A, Liu C, Putcha N, et al.
Am J Respir Crit Care Med . 2022 Oct; 207(6):721-730. PMID: 36288428
Indoor air pollution represents a modifiable risk factor for respiratory morbidity in chronic obstructive pulmonary disease (COPD). The effects of indoor air pollution, as well as the impact of interventions...
28.
Hassan H, Naranjo M, Ayoub N, Housten T, Hsu S, Balasubramanian A, et al.
Am J Respir Crit Care Med . 2022 Sep; 207(3):312-322. PMID: 36173815
To date, it remains unclear whether recent changes in the management of patients with systemic sclerosis-associated pulmonary hypertension (SSc-PH) have improved survival. To describe a cohort of patients with SSc-PH...
29.
Balasubramanian A, Putcha N, MacIntyre N, Jensen R, Kinney G, Stringer W, et al.
Ann Am Thorac Soc . 2022 Aug; 20(1):38-46. PMID: 35969416
Chronic obstructive pulmonary disease (COPD) mortality risk is often estimated using the BODE (body mass index, obstruction, dyspnea, exercise capacity) index, including body mass index, forced expiratory volume in 1...
30.
Sharp M, Psoter K, Balasubramanian A, Pulapaka A, Chen E, Brown S, et al.
Ann Am Thorac Soc . 2022 Aug; 20(1):30-37. PMID: 35926103
Historically, sarcoidosis was described as a restrictive lung disease, but several alternative phenotypes of pulmonary function have been observed. Pulmonary function phenotypes in sarcoidosis may represent different clinical and/or molecular...